C
ELL GROWTH RELIES on cell cycle progression, requiring several regulators including p53, retinoblastoma (Rb), cyclins, cyclin-dependent kinases (cdks), and cdk inhibitors such as p21 and p16 (1, 2) . DNA synthesis, chromosome segregation, spindle assembly, and cytokinesis all occur in ordered sequence during the cell cycle. Loss or mutation of genes controlling these processes leads to dysfunctions of cell cycle progression and frequently to tumorigenesis and apoptosis. For example, mice lacking p53 show unregulated G 1 checkpoint control and a high prevalence of spontaneous tumor development (3); mice lacking Rb do not survive fetal development while Rbϩ/Ϫ mice developed pituitary tumors at 8 months (4); mice lacking p21 undergo normal development but show defective G 1 checkpoint control (5) . Recently, a family of proteins including securins, separins, and cohesins were found to play important roles in sister chromatid separation during M phase (6) and exhibit characteristics of cell cycle regulators. Securin proteins (Saccharomyces cerevisiae Pds1p, Schizosaccharomyces prombe Cut2, Drosophila pimples, Xenopus securin) reach highest expression levels in M phase and share at least one destruction box and a nineamino acid consensus motif [RX (A or V or L) LGXXX N] originally identified in B-type cyclins (7) (8) (9) (10) . The separins (Esp1p, Cut1, BimB) share a conserved carboxyterminal domain, which binds to securins (7, 8, 11) . Securin accumulation during interphase and their binding to separin prevents premature separin activation. During a normal cell cycle, anaphase promoting complex (APC) eventually degrades securin, thus activating separin to facilitate chromosome segregation (6) . In this sense, securins function as inhibitors of chromatid separation during anaphase. Thus far, mammalian securin or separin characterization has been limited (9) .
Pituitary tumor transforming gene (PTTG) has 44.6% amino acid identity with Xenopus securin, and PTTG contains a destruction box (RXLGXXXN) and cyclin Blike nine-amino acid consensus motif (9) . Originally isolated from pituitary tumor GH-secreting cells by differential display, PTTG is considered a protooncogene because PTTG overexpression in NIH3T3 cells induces cell transformation and in vivo tumor formation (12) . Although abundant only in normal testis and thymus (13), PTTG is highly expressed in various human tumors and is responsive to E induction (14, 15) . Moreover, PTTG mediates promoter transcriptional activation (16) and utilizes c-myc as its downstream gene target (17) . Indeed, PTTG preferentially localizes in the nucleus (18) , its expression levels change in a temporal pattern during cell cycle progression peaking during M phase, and it is phosphorylated by cdc2 and MAPK (19, 20) .
Yeast securin Pds1p deletion mutants separate sister chromatids inefficiently and are lethal at 37 C, but these mutants survive and proliferate at 25 C with unaffected sister chromatid separation (7) . Drosophila securin pimples loss mutation results in defective sister chromatid separation during mitosis, defective cytokinesis, and recessive lethality (10) . More recently, inactivation of human securin (hsecurin) in a karyotypically stable human colorectal cancer cell line resulted in a higher chromosome loss rate in these cells while remaining viable (21) . To understand mammalian securin PTTG function, we disrupted the murine PTTG gene by homologous recombination. We report here that mice lacking PTTG are, in contrast to yeast or Drosophilalacking securin, viable; but they show testicular and splenic hypoplasia, thymic hyperplasia, thrombocytopenia, aberrant cell cycle progression, chromosome instability, and premature centromere division.
RESULTS

PTTG ؊/؊ Mice Are Viable and Fertile
In the targeting vector, part of exon I including the ATG start codon, exon II, and exon III were replaced by a neomycin cassette (Fig. 1a) resulting in a PTTG null mutation, as determined in both Southern and Northern blot (Fig. 1, b and c) .
Surprisingly, in contrast to the lethal phenotypes of yeast or Drosophila lacking securin, PTTG knockout mice are viable and fertile. Of the first 100 F 2 progeny, 23 were PTTG ϩ/ϩ, 51 were PTTG ϩ/Ϫ, and 26 were PTTG Ϫ/Ϫ, suggesting that PTTG deficiency did not result in significant intrauterine mortality. Nonetheless, PTTG Ϫ/Ϫ mice demonstrate female subfertility, e.g. in 15 pairs of breeding, the average litter size derived from a PTTG Ϫ/Ϫ dam (3-5 pups per litter) was less than half of the litter size from a PTTG ϩ/Ϫ or ϩ/ϩ dam (7-11 pups per litter) ( Table 1) .
PTTG ؊/؊ Mice Demonstrate Testicular and Splenic Hypoplasia, Thymic Hyperplasia, and Thrombocytopenia PTTG Ϫ/Ϫ mice had reduced testicle weight, reduced spleen weight, and enlarged thymus ( Table 2 , Fig. 2a ), while ovarian weights did not differ. Testicular hypoplasia was more severe in sexually mature than in immature mice ( Table 2 ). The PTTG Ϫ/Ϫ adult testicle weight is 45-55% of PTTG ϩ/ϩ animals. Splenic hypoplasia was apparent after weaning and continued for up to 8 months observation time: PTTG Ϫ/Ϫ spleen weight 50-75% of PTTG ϩ/ϩ. Thymic hyperplasia was also observed approximately 4 wk after birth and continued up to 8 months observation, with PTTG Ϫ/Ϫ thymus weight 115-135% of PTTG ϩ/ϩ. Thymic hyperplasia was more pronounced at an early age (4-5 wk). PTTG is abundantly expressed in normal testis and thymus, but not in spleen or ovary (13) . The weight changes observed in testis and thymus thus suggest cell type differences in PTTG effects on cell growth. In the presence of thymic overgrowth, and as the spleen is composed mainly of T and B cells, reduced PTTG Ϫ/Ϫ spleen weight suggests reduced B cell population and weakened antibody production. This is supported by impaired IgM and IgG1a antibody production in PTTG Ϫ/Ϫ mice when keyhole limpet hemocyanin is used as an immunogen (unpublished data). In the thymus, thymic hyperplasia is probably not due to reduced apoptosis, as PTTG Ϫ/Ϫ thymocytes demonstrated similar in vitro responses to 20 nM dexamethasone or 3 grays (Gy) irradiation as compared with wild-type (WT) thymocytes (data not shown), and similar to GADD45a Ϫ/Ϫ mice with thymic hyperplasia despite functioning thymocyte apoptosis mechanisms (22) . Nevertheless, the distribution of CD4ϩCD8ϩ, CD4ϩCD8Ϫ, and CD4ϪCD8ϩ thymocytes differed significantly after PTTG disruption ( Fig. 2b ): CD4ϩCD8Ϫ thymocytes represent approximately 13.5% of total PTTG Ϫ/Ϫ thymocytes vs. about 6.5% in PTTG ϩ/ϩ mice. Moreover, hematological analysis showed that PTTG Ϫ/Ϫ mice are thrombocytopenic, despite normal bone marrow megakaryocyte numbers. PTTG Ϫ/Ϫ platelet numbers ranged from 40-65% of PTTG ϩ/ϩ mice, and PTTG Ϫ/Ϫ mice bleeding time was prolonged (16-19 min vs. 5-10 min in PTTG ϩ/ϩ mice, P Ͻ 0.005) (Fig. 2c) .
PTTG ؊/؊ MEFs Exhibit Aberrant Cell Cycle
Progression, Chromosome Instability, and Premature Centromere Division PTTG Ϫ/Ϫ and PTTG ϩ/ϩ mouse embryonic fibroblasts (MEFs) both derived at passage 3 demonstrated similar doubling times (ϳ30 h) but different cell cycle parameters (Fig. 3a) . The PTTG Ϫ/Ϫ MEF G 1 phase was shortened (10.1 vs. 18.2 h), with a prolonged G 2 -M phase (7.2 vs. 1.4 h), implying deficient G 0 -G 1 checkpoint control and delayed progression of G 2 -M. PTTG Ϫ/Ϫ MEFs showed a flow cytometric pattern similar to a pattern in DNA-damaged cell population such as one that was observed in ␥-irradiated WT PTTG ϩ/ϩ MEFs (Fig. 3b) .
In more detailed flow cytometry analysis, untreated WT PTTG ϩ/ϩ MEFs exhibit 62-75% in G 0 -G 1 , 15-27% in S, and 3-10% in G 2 -M phases, respectively, during 96 h observation. In contrast, 37-54% of PTTG Ϫ/Ϫ MEFs were in the G 0 -G 1 phase, 13-32% in S phase, and 27-43% in the G 2 -M phase (Fig. 3b) . After ␥-irradiation, the number of PTTG ϩ/ϩ MEFs in G 2 -M phase increased to 28-51%, while 45-62% of PTTG Ϫ/Ϫ MEFs were in the G 2 -M phase (Fig. 3b) , implying that the G 2 -M checkpoint is functional in both ␥-irradiated PTTG ϩ/ϩ and PTTG Ϫ/Ϫ MEFs (Fig. 3b) . Interestingly, introduction of PTTG into PTTG Ϫ/Ϫ MEFs via retroviral transfection substantially increased the number of cells in S phase (ϳ40% at 72 h vs. ϳ19% at baseline) while reducing the number of cells in G 2 -M (ϳ10% at 72 h vs. ϳ29% at baseline) (Fig. 3b) , reflecting phenotype reversal of PTTG Ϫ/Ϫ MEF cells showing a large G 2 -M phase. Moreover, more than 85% PTTG ϩ/ϩ MEFs were in G 0 -G 1 after 96 h serum starvation, while only 65% PTTG Ϫ/Ϫ MEFs were in G 0 -G 1 with Ͼ20% PTTG Ϫ/Ϫ MEFs still residing in G 2 -M after serum starvation (Fig. 3b) .
Cytogenetic analysis of PTTG Ϫ/Ϫ MEFs showed damaged nuclei and aberrant chromosome morphology, especially around centromeric regions. Nuclear observation showed that 12-15% PTTG Ϫ/Ϫ MEFs were binucleated or multinucleated vs. Ͻ1% of PTTG ϩ/ϩ MEFs (Fig. 4a) . In chromosome spreads, PTTG Ϫ/Ϫ MEFs demonstrated enhanced aneuploidy and several aberrant chromosome morphologies (Fig. 4b) . Ten to 15% of PTTG Ϫ/Ϫ MEFs were aneuploid vs. approximately 1% of PTTG ϩ/ϩ MEFs, and aberrant chromosome morphologies including quadriradials, triradials, and breaks were observed in 4-6% of PTTG Ϫ/Ϫ metaphase spreads examined, while no such anomalies were observed in PTTG ϩ/ϩ MEFs. Also, about 6% of PTTG Ϫ/Ϫ MEFs are apoptotic in contrast to virtually no apoptosis observed in PTTG ϩ/ϩ MEFs, as assessed by Hoescht staining. One possibility is that the binucleated and multinucleated cells probably contribute to the observed higher percentage of PTTG Ϫ/Ϫ MEFs in G 2 -M as assessed by flow cytometry, as well as to the aneuploidy.
Significantly, premature centromere division was observed in approximately 10% of chromosome spreads of PTTG Ϫ/Ϫ MEFs vs. none in PTTG ϩ/ϩ MEFs (Fig. 5) . Premature centromere division is defined as separation of the centromere region preceding completion of chromosome arm separation. Normally, the centromere region is the last region to separate. In the 5 of 54 chromosome spreads of PTTG Ϫ/Ϫ MEFs with premature centromere division, 2-5 chromosomes were affected in each cell. No such premature centromere division was observed in PTTG 
These results were obtained from at least three breeding pairs except for M(ϩ/ϩ) ϫ F(ϩ/ϩ) or M(Ϫ/Ϫ) ϫ F(Ϫ/Ϫ) where 15 breeding pairs were used.
ϩ/ϩ MEFs. However, the presence of these aberrant chromosome structures in the PTTG Ϫ/Ϫ MEFs was not lethal for the entire cell population.
DISCUSSION
We have observed PTTG Ϫ/Ϫ mice for up to 8 months and report here that these mice exhibit distinct cellular and physiological phenotypes. Surprisingly, in contrast to the phenotypes observed in yeast or Drosophila securin loss mutants, PTTG Ϫ/Ϫ mice are viable and fertile. The nonfatal phenotype suggests that mammalian sister chromatid separation, one of the most important transitions in the cell cycle, is regulated by more than one mechanism involving securin, separin, and cohesin. In a normal cell cycle, sister chromatid pairs generated during the eukaryotic S phase remain paired through G 2 and during the initial phase of mitosis (prophase) while chromatin is con- 
All values are mean Ϯ SD (n ϭ 5-6 per group). densed and the spindle assembled (6) . Sister chromatid cohesin is ultimately disrupted at the metaphaseanaphase transition allowing appropriate segregation (6) . Both cleavage and non-cleavage-associated cohesin removal pathways regulate cohesin dissociation from chromatin during prophase/prometaphase (6, 23), while critical cohesin removal from heterochromatic regions is achieved by separin-mediated cleavage (6). Accordingly, loss of securin, the inhibitor to separin function, would lead to constitutive separin activation, allowing cohesin removal from heterochromatic regions resulting in premature centromere division. The observation of premature centromere division in PTTG Ϫ/Ϫ MEF metaphase spreads is a novel demonstration of the required balance between chromosomes and interacting protein complexes. Nonetheless, the extent of premature centromere division in most Ϫ/Ϫ cells does not appear lethal, and it is thus likely that other mechanisms compensate for premature centromere division in PTTG Ϫ/Ϫ MEFs. Interestingly, increased premature centromere division and aneuploidy in aging postovulatory mouse oocytes is coupled with reproductive failure and/or embryonic cytogenetic aberrations (24) . Thus, premature centromere division in PTTG Ϫ/Ϫ mice may be a cause of the observed PTTG Ϫ/Ϫ female subfertility.
Indeed, a recent observation in an in vitro hsecurininactivated cell system also showed that hsecurindeficiency was not lethal to cells (21) . These cells exhibited defective execution of anaphase associated with incomplete sister chromatid separation, leading to budded nuclei, chromosomal instability, and gross aneuploidy (21) . Nevertheless, anaphase eventually did occur in most hsecurin Ϫ/Ϫ cells, suggesting that an additional mechanism for separin regulation exists in normal cells and basal separin proteinase activity persists in hsecurin-deficient cells, allowing mitosis to progress. These hsecurin-deficient cells were derived from HCT116 cells, a colorectal cancer cell line with a stable near-diploid karyotype (21) , and the observations in these cells are similar to those we observed in the PTTG Ϫ/Ϫ MEF cells: both cells had doubling times comparable to their respective control cells, abnormal nuclear morphology, chromosomal instability, and increased aneuploidy. Overall, securin (PTTG) deficiency in either cell type did not severely affect cell survival. Quadriradial and triradial chromosome patterns are indications of rare somatic chromosome exchange events. These patterns have been observed in hereditary diseases such as Bloom's syndrome and Fanconi anemia (25, 26) . Similar quadriradial and triradial patterns have only been observed in a knockout mouse model with targeted truncation in the murine DNA repair gene Brca2 (27) . Nevertheless, the genetic mechanism underlying these chromosomal aberrations in the PTTG knockout model may differ from that in the Brca2 knockout model: absence of securin PTTG promotes premature centromere division and stabilizes formation of quadriradials and triradials; while loss of Brca2 fails to clear spontaneous chromosome aberrations including quadriradials or triradials.
These results show that PTTG appears to be critical for maintenance of chromosome stability and cell cycle progression, as similarly suggested by observations in hsecurin-deficient cells (21) . Moreover, disrupted PTTG also leads to testicular and splenic hypoplasia, thymic hyperplasia, and thrombocytopenia. Reduced testis size has been observed in mice lacking genes required in testicular development, including cyclin D2 (28), cdk 4 (29), cdk 4 inhibitor p19ink4d (30, 31), E2F-1 (32), Egr 4 (33), and TATAbinding protein-related factor Trf 2 (34). Although tes- tis size correlates well with mice sperm counts (31), reduced sperm counts did not necessarily lead to infertility in these mice. Our result implies a role for PTTG in spermatogenesis, which is under ongoing study in our laboratory. The requirement for established G 1 and S phase regulators, including cyclin D2, cdk 4, p19ink4d, and E2F-1, in testicular development suggests that these proteins regulate G 1 and S phase progression during spermatogenesis. As PTTG peaks during the M phase, PTTG could play independent and/or complementary roles to these G 1 and S phase regulators during spermatogenesis.
Disruption of several genes, including thrombopoietin, thrombopoietin receptor c-mpl, GATA-1, and NF-E2, resulted in decreased megakaryocytes, decreased platelets, and increased bleeding time (35) (36) (37) . However, deletion of the ␣-subunit of guanine-nucleotide-binding protein Gq resulted in increased bleeding times with normal megakaryocyte and platelet numbers (38) . Disrupted CD39, a vascular ATP diphosphohydrolase, did not alter megakaryocyte number, but resulted in approximately 20% lower platelet counts and prolonged bleeding times (39) . As platelet formation from megakaryocytes involves multiple mitotic events, PTTG could play a role during the process. Human PTTG localizes to chromosome 5q33 (14) , and 5q deletions (5q21, 5q31-33) occur in several hematological dysplasias including pediatric thrombocytopenia and the 5q syndrome (40, 41) . The human thrombin receptor gene also localizes to 5q13 (42) , and it is therefore likely that 5q is the locus for factors required for appropriate hematopoiesis, including PTTG.
It is likely that chromosomal and cell cycle changes caused by PTTG loss result in unique tissue-specific phenotypic responses in PTTG-abundant tissues, as evidenced by the observed testis hypoplasia and thymus hyperplasia. PTTG may therefore possess cell type-specific growth-stimulatory or -inhibitory effects. As PTTG is usually overexpressed in tumors, it will be interesting to observe the tissue-specific growth effect of PTTG deprivation in tumors derived from various tissue types. Our observations demonstrate that PTTG Ϫ/Ϫ mice exhibit unique phenotypes that will likely unravel underlying mechanisms for PTTG action.
MATERIALS AND METHODS
Experimental Animals
All animal experimentation in this study was conducted in accord with Institutional Animal Care & Use Committee 
Plasmids and Cells
A retroviral plasmid pLPCX-PTTG was generated by subcloning murine PTTG cDNA into pLPCX (CLONTECH Laboratories, Inc., Palo Alto, CA) via EcoRI and NotI sites. A viral packaging cell line Eco293 was purchased from CLONTECH Laboratories, Inc. Retrovirus was produced by transfecting pLPCX-PTTG into Eco293 cells and harvesting supernatants 48 h after transfection. The viral titers were between 5 ϫ 10 5 /ml to 1 ϫ 10 6 /ml.
Generation of PTTG ؊/؊ Mice
A 16-kb NotI fragment containing the entire murine PTTG coding region was isolated from a mouse 129 SvEv genomic library (Stratagene, La Jolla, CA) using a PTTG probe (13) . The targeting vector contained the equivalent of approximately 12.5 kb murine PTTG genomic DNA with a 4-kb deletion, including part of the first exon containing the ATG start codon, exons 2 and 3, through the middle of the third intron replaced with pGK-neo. The targeting vector was linearized with NotI, electroporated into J1 embryonic stem (ES) cells, and selected in 0.4 mg/ml G418. A 345-bp fragment external to the 5Ј-end of the targeting construct was used as the probe. From 800 ES colonies, 5 clones were identified with correct homologous recombination by Southern blot analysis. A 1.7-kb hybridizing fragment corresponds to the WT PTTG allele, while a 4.9-kb hybridizing fragment corresponds to the targeted PTTG allele. PTTG ϩ/Ϫ ES cells were then microinjected into C57BL6 blastocysts, and germline transmission was observed in male chimeras representing two separate ES cell clones. Chimeras were crossed with the C57BL6 strain for the production of knockout mice. Murine offspring were genotyped by either genomic Southern blot as described above or PCR. For PCR, cycling parameters were 94 C for 20 sec, 56 C for 20 sec, and 72 C for 1 min for 30 cycles; primers PTTG2S (5Ј-GGTTTCAACGCCAC-GAGTCG-3Ј) and PTTG1AS (5Ј-CTGGCTTTTCAGTA-ACGCTGTTGAC-3Ј) were used for WT PTTG detection of 114 bp fragment; primers GENO1S (5Ј-GTGTGAAGGGGGAG-GCTCCAATC-3Ј) and GENO4AS (5Ј-GTGCTACTTCCATTT-GTCACGTCC-3Ј) were used for targeted PTTG detection of 596 bp fragment. Blood samples from PTTG Ϫ/Ϫ and PTTG ϩ/ϩ mice were collected for hematological analysis including whole blood counting and blood and bone marrow smears. Femurs were sectioned for morphological examination and megakaryocyte counting. Bleeding time was measured as described previously (38) .
Southern and Northern Blot Analysis
For Southern blot analysis, genomic DNA from ES cells or mice tails were digested with HindIII, electrophoresed in 1% agarose gel, blotted onto Hybond-N membrane (Amersham Pharmacia Biotech, Arlington Heights, IL), and hybridized using QuikHyb (Stratagene). The probe is a 345-bp fragment upstream of exon 1 and is illustrated in Fig. 1a .
For Northern blot analysis, total RNA was prepared using Trizol (Life Technologies, Inc., Gaithersburg, MD), electrophoresed in 1% formaldehyde denaturing gel, and blotted onto Hybond-N membrane (Amersham Pharmacia Biotech Inc., Piscataway, NJ). A DNA fragment covering mPTTG exon 2 and 3 cDNA sequence (372 bp) was used as probe, and glyceraldehyde-3-phosphate dehydrogenase was used as internal control.
Cell Culture and Transfection
PTTG ϩ/ϩ and Ϫ/Ϫ MEFs were prepared from embryonic day 13.5 (E13.5) embryos as described (27) and maintained in DMEM with 10% FBS. Cells at passages 3-5 were plated at 4 ϫ 10 5 per 60-mm dish, and either irradiated (12 Gy) from a 137Cs Gammacell 40 irradiator (Nordion International, Inc., Kanata, Ontario, Canada) or DMEM was added with 0.1% FBS in separate experiments. Cells were harvested at the indicated times for cell cycle analysis. For retroviral transfection experiments, PTTG ϩ/ϩ and Ϫ/Ϫ cells were infected with PTTG expression retrovirus produced from Eco 293 packaging cells transfected by pLPCX-PTTG plasmid encoding full-length PTTG protein, and subjected to cell cycle analysis.
Thymic lymphocytes were isolated from PTTG ϩ/ϩ and PTTG Ϫ/Ϫ mice aged 5-6 wk and cultured in RPMI 1640 medium. Isolated thymocytes were also stained for CD4 and CD8 surface expression using PE-labeled anti-CD4 (L3T4) and fluorescein isothiocyanate-labeled anti-CD8 (Ly-2) (BD PharMingen, San Diego, CA) and analyzed using FACStar (Becton Dickinson and Co., San Jose, CA).
Flow Cytometry
Cells were trypsinized at the indicated times, washed with PBS, resuspended in 1 ml PBS, fixed with 2 ml cold methanol, treated with propidium iodide and ribonuclease A, and subjected to cell cycle analysis using FACStar (Becton Dickinson and Co.).
Nuclear and Chromosome Analysis
For nuclear analysis, MEFs grown on chamber slides were immunostained with anti-␣-tubulin and rhodamine-antigoat secondary antibody and counterstained with Hoescht 33258 (43) . For chromosome analysis, mitotic MEFs were collected after 16 h colcemid treatment (50 ng/ml), hypotonized, and fixed with cold Carnoy's fixative. Fixed cells were processed by standard cytogenetic procedures. Chromosome number and gross rearrangements were determined in at least 50 metaphase cells.
